Trametinib and Everolimus for the Treatment of Pediatric and Young Adult Patients With Recurrent Low Grade Gliomas and High Grade Gliomas (PNOC021)

Go Back to All Clinical Trials

Trametinib and Everolimus for the Treatment of Pediatric and Young Adult Patients With Recurrent Low Grade Gliomas and High Grade Gliomas (PNOC021)

Brief description of study

Clinical Study Identifier: s20-01427

ClinicalTrials.gov Identifier: NCT04485559

Principal Investigator: Jessica Clymer.

Other Investigator: Devorah Segal.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies